2a0x Citations

Neighboring group participation in the transition state of human purine nucleoside phosphorylase.

Biochemistry 46 5038-49 (2007)
Related entries: 2a0w, 2a0y, 2oc4, 2oc9, 2on6

Cited: 32 times
EuropePMC logo PMID: 17407325

Abstract

The X-ray crystal structures of human purine nucleoside phosphorylase (PNP) with bound inosine or transition-state analogues show His257 within hydrogen bonding distance of the 5'-hydroxyl. The mutants His257Phe, His257Gly, and His257Asp exhibited greatly decreased affinity for Immucillin-H (ImmH), binding this mimic of an early transition state as much as 370-fold (Km/Ki) less tightly than native PNP. In contrast, these mutants bound DADMe-ImmH, a mimic of a late transition state, nearly as well as the native enzyme. These results indicate that His257 serves an important role in the early stages of transition-state formation. Whereas mutation of His257 resulted in little variation in the PNP x DADMe-ImmH x SO4 structures, His257Phe x ImmH x PO4 showed distortion at the 5'-hydroxyl, indicating the importance of H-bonding in positioning this group during progression to the transition state. Binding isotope effect (BIE) and kinetic isotope effect (KIE) studies of the remote 5'-(3)H for the arsenolysis of inosine with native PNP revealed a BIE of 1.5% and an unexpectedly large intrinsic KIE of 4.6%. This result is interpreted as a moderate electronic distortion toward the transition state in the Michaelis complex with continued development of a similar distortion at the transition state. The mutants His257Phe, His257Gly, and His257Asp altered the 5'-(3)H intrinsic KIE to -3, -14, and 7%, respectively, while the BIEs contributed 2, 2, and -2%, respectively. These surprising results establish that forces in the Michaelis complex, reported by the BIEs, can be reversed or enhanced at the transition state.

Articles - 2a0x mentioned but not cited (3)

  1. Neighboring group participation in the transition state of human purine nucleoside phosphorylase. Murkin AS, Birck MR, Rinaldo-Matthis A, Shi W, Taylor EA, Almo SC, Schramm VL. Biochemistry 46 5038-5049 (2007)
  2. Binding pocket optimization by computational protein design. Malisi C, Schumann M, Toussaint NC, Kageyama J, Kohlbacher O, Höcker B. PLoS One 7 e52505 (2012)
  3. Molecular docking investigation of the amantadine binding to the enzymes upregulated or downregulated in Parkinson's disease. Ionescu MI. ADMET DMPK 8 149-175 (2020)


Reviews citing this publication (3)

  1. Binding isotope effects: boon and bane. Schramm VL. Curr Opin Chem Biol 11 529-536 (2007)
  2. Enzymatic Transition States and Drug Design. Schramm VL. Chem Rev 118 11194-11258 (2018)
  3. From crystal to compound: structure-based antimalarial drug discovery. Drinkwater N, McGowan S. Biochem J 461 349-369 (2014)

Articles citing this publication (26)